Epigene Labs
PrivateLast Round
VC Round
Nov 29, 2023
Total Funding Raised
$5.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Epigene Labs operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a VC Round in November 2023.
Epigene Labs is a biotechnology company that develops an AI-powered platform for data aggregation and analysis to accelerate precision oncology research and drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Epigene Labs Comparables
Compare Epigene Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sonrai Analytics | 90% | |
| ADLIN Science | 80% | |
| Concr | 78% |
For institutional investors. Book with your work email.
Epigene Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 29, 2023 | ||||
| Grant | Jul 1, 2022 | ||||
| Grant | Dec 1, 2021 | ||||
| Seed | Jul 1, 2020 | ||||
| Seed | Mar 31, 2020 | ||||
Accelerator | Sep 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Epigene Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Harvard Innovation Labs | Accelerator |
| European Commission | Grant |
| UI Investissement | VC Round, Pre Seed |
| Daphni | VC Round, Pre Seed, Seed |
| XAnge | VC Round, Seed |
| Bpifrance | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors increased 32% MoM.
- Jul 25, 2026
Monthly visitors increased 771% MoM.
For institutional investors. Book with your work email.
Epigene Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Epigene Labs's valuation, stock price, and market status.
Is Epigene Labs a public or private company?
Epigene Labs is a private company.
What is the current stock price of Epigene Labs?
Epigene Labs is a private company, so its shares have no public market price. Caplight tracks Epigene Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Epigene Labs worth (valuation)?
Valuation information for Epigene Labs is not publicly available.
Can I buy Epigene Labs stock?
Epigene Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Epigene Labs's last funding round?
Epigene Labs's most recent funding round was VC Round on November 29, 2023.
Who are the main investors in Epigene Labs?
Key investors in Epigene Labs include UI Investissement, Daphni, XAnge.
Will Epigene Labs IPO soon?
No public IPO plans have been announced for Epigene Labs.
How can I track Epigene Labs secondary market activity?
Caplight tracks bids, offers, and trades in Epigene Labs's shares on secondary markets.